María Eva Mingot‐Castellano

Author

Hospital Regional Universitario de Málaga ORCID

Also Known As

Chavele, K, E CASTELLANO, E. Mingot, Eva Maria Mingot‐Castellano, Eva Mingot, Eva Mingot Castellano, H.-B Kim, M CASTELLANO, M E Mingot Castellano, M E Mingot-Castellano

179

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Hospital Regional Universitario de Málaga Hospital Universitario Virgen del Rocío Vall d'Hebron Hospital Universitari Hospital Clínico San Carlos Hospital General Universitario Gregorio Marañón

About

María Eva Mingot‐Castellano is an author at Hospital Regional Universitario de Málaga specializing in hematology, medicine, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	763
2	Health Sciences	4	4	671
3	Public Health	2	2	81
4	Blood Transplantation	1	1	11
5	Cellular Therapies	1	1	11

María Eva Mingot‐Castellano

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A Angela Huth‐Kühne, F. Baudo, Peter W. Collins, Haematologica ImmunohematologyInternational RecommendationsThrombosisTranslational MedicineLaboratory Hematology	2009	426
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A Peter W. Collins, F. Baudo, Angela Huth‐Kühne, BMC Research Notes	2010	188
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia Tomás José González‐López, Cristina Pascual, María Román, American Journal of Hematology ImmunohematologyImmunodeficienciesImmunologyPathologyPharmacotherapy	2014	148
Use of the Zarit scale for assessing caregiver burden and collapse in caregiving at home in dementias Ana M. Gort, María Eva Mingot‐Castellano, Xavier Gómez, International Journal of Geriatric Psychiatry	2007	99
Evaluation of the utility of the <scp>ISTH</scp>‐<scp>BAT</scp> in haemophilia carriers: a multinational study Paula James, Johnny Mahlangu, Christoph Bidlingmaier, Haemophilia	2016	90
Use of eltrombopag after romiplostim in primary immune thrombocytopenia José Ramón González‐Porras, María Eva Mingot‐Castellano, Marcio Andrade, British Journal of Haematology	2014	77
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa, The Lancet ThrombopoiesisAutoimmune DiseaseBlood PlateletPrimary Immune ThrombocytopeniaImmunology	2023	77
Evans syndrome in adults: an observational multicenter study Bruno Fattizzo, Marc Michel, Juri Alessandro Giannotta, Blood Advances	2021	66
Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content Nuria Revilla, Javier Corral, Antonia Miñano, Platelets	2018	59
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients Nina Borràs, Javier Batlle, Almudena Pérez‐Rodríguez, Haematologica	2017	54

Page 1